NASOPHARANGEAL CANCER
Clinical trials for NASOPHARANGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARANGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARANGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could delaying radiation be just as effective for advanced throat cancer?
Disease control Recruiting nowThis study is for people with nasopharyngeal cancer that has spread to other parts of the body. Researchers want to see if giving radiation only when needed (salvage therapy) works as well as giving it right away after a combination of chemotherapy and immunotherapy. The goal is …
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Immunotherapy combo shows promise in High-Risk throat cancer trial
Disease control Recruiting nowThis study is for people with a high-risk type of nasopharyngeal cancer (a throat cancer linked to the Epstein-Barr virus). It compares a new treatment sequence—immunotherapy plus chemotherapy, then radiation with more immunotherapy—against a standard maintenance drug (capecitabi…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New hope for Hard-to-Treat HER2 cancers: T-DXd under Real-World study
Disease control Recruiting nowThis study looks at how well the drug T-DXd works for people with advanced HER2-positive solid tumors who have already tried other treatments and have no good options left. About 100 adults in the US will be followed to see if their tumors shrink or stop growing. The goal is to u…
Matched conditions: NASOPHARANGEAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 02:49 UTC
-
New combo therapy offers hope for advanced nose cancer patients
Disease control Recruiting nowThis study tests whether adding low-dose radiation to a standard chemotherapy and immunotherapy combination can help control advanced nasopharyngeal cancer that has returned or spread. About 55 adults aged 18-65 with this type of cancer will receive the treatment. The goal is to …
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New combo therapy aims to control returning throat cancer
Disease control Recruiting nowThis study tests a treatment plan for people whose nasopharyngeal cancer has returned after initial therapy. Participants first receive a combination of immunotherapy (PD-1 inhibitor) and chemotherapy. Those who respond well are then randomly assigned to get either immediate re-i…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Can a simple antiseptic spray stop radiation burns? new trial aims to find out
Prevention Recruiting nowThis study tests whether a topical chlorhexidine spray can prevent severe skin reactions caused by radiation therapy in people with nasopharyngeal cancer. About 148 participants will receive either the spray or a placebo during their radiation treatment. The goal is to see if the…
Matched conditions: NASOPHARANGEAL CANCER
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated May 13, 2026 15:59 UTC